newsfilter
← Latest News
GlobeNewswire·

SenesTech Reports Record Q3 2026 Revenue with 59% Year-Over-Year Growth

SNES
  • SenesTech reported Q3 2026 total revenue of $1.097 million, a 42% sequential increase & 59% year-over-year growth, marking the first quarter above $1 million.
  • E-commerce revenue grew 52% sequentially to account for 71% of total Q3 revenue, while subscription revenue rose 53% sequentially with a 72% increase in combined subscribers.
  • Direct B2B revenue increased 19% sequentially, driven by process changes in pest management, government, & commercial verticals.
  • Evolve® revenue reached $979,000 (up 67% year over year) representing 89% of product revenue, while ContraPest® revenue was $118,000 (up 13% year over year).
  • Gross profit hit a record $796,000, a 40% sequential increase, with gross margin at 72.6%.
  • The company reported a net loss of $2.0 million for the quarter, an increase from $1.8 million in Q2 2026.
  • Adjusted EBITDA loss was $1.4 million, flat compared to Q2 2026 but higher than the $1.1 million loss in Q3 2025.
  • Cash & cash equivalents stood at $4.0 million at quarter end, with an additional $1.2 million raised via ATM subsequent to the quarter.
  • Net cash used in operating activities declined to $1.3 million in Q3 2026, down from $1.7 million in Q2 2026.
  • Strategic updates included expanding the B2B sales team to four members, adding Grove Collaborative as an e-commerce channel, & launching assessment services for B2B customers.
  • Municipal programs in Chicago & Swampscott, Massachusetts, demonstrated significant reductions in rodent activity using SenesTech products.
  • Sandstrom Partners was engaged as a strategic advisor to support branding & marketing initiatives.
  • The company plans to add two more salespeople by year-end to support B2B growth efforts.
Company
SenesTech
Keywords
Nasdaq:SNES, SenesTech, SenesTech, SNES, Pest Control, Pest Management, Rodent Birth Control, Rodent Control, Evolve, ContraPest, Earnings